U.S. President Donald Trump signed an executive order aimed at expanding access to in vitro fertilization (IVF) and reducing treatment costs. The order directs the administration to develop policy recommendations within 90 days to protect IVF access and lower expenses. However, it does not specify funding sources.
Currently, most states do not mandate insurance coverage for IVF, which involves fertilizing eggs and sperm in a lab. Even with insurance, costs can range from $12,000 to $25,000 per cycle, often requiring multiple attempts. The White House stated that over 85,000 babies were born through IVF in 2021, citing data from the Department of Health and Human Services.
Trump’s order seeks to remove unnecessary legal and regulatory hurdles that drive up costs, reinforcing his campaign promise to ensure government or insurance-backed IVF funding. The U.S. fertility rate has been declining, dropping 3% in 2023 and averaging a 2% annual decrease between 2014 and 2020. In 2022, the birth rate was 1.67 births per woman, below the 2.1 replacement rate necessary for population stability without immigration.
IVF became a key election issue following a controversial Alabama Supreme Court ruling that classified embryos as children, raising concerns about embryo storage and transportation. The decision led some patients to consider moving their embryos out of the state. Senate Republicans blocked Democratic-led IVF protection legislation twice in 2024, arguing that access was not at risk.
Trump’s executive order mandates a review of policies contributing to high IVF costs, including those requiring legislative changes. His initiative underscores the growing political focus on reproductive healthcare and its impact on families struggling with infertility.


CDC Shake-Up Sparks Vaccine Policy Clash Between RFK Jr. and Susan Monarez
Australia Moves Forward With Teen Social Media Ban as Platforms Begin Lockouts
U.S. Defense Chief Pete Hegseth Defends Controversial Second Strike on Suspected Drug-Smuggling Vessel
Michael Dell Pledges $6.25 Billion to Boost Children’s Investment Accounts Under Trump Initiative
California Launches Portal for Reporting Alleged Misconduct by Federal Immigration Agents
Obamacare Premiums Set to Double in 2026 as Subsidy Expiration Looms Amid U.S. Shutdown
U.S. to Reduce Import Duties on South Korean Autos Under New Trade Agreement
Pfizer Boosts Bid for Metsera Amid Intensifying Rivalry with Novo Nordisk in Obesity Drug Market
Trump Administration Halts Immigration, Green Card, and Citizenship Processing for 19 Countries
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
FDA Memo Raises Questions About Possible COVID-19 Vaccine Links to Rare Child Deaths
Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates
Cuba Reaffirms Anti-Drug Cooperation as Tensions Rise in the Caribbean
Israel Receives Body of Deceased Hostage as Rafah Crossing Reopening Hinges on Final Returns
U.S. Soybean Shipments to China Gain Momentum as Trade Tensions Ease
Trump Administration Plans Major Rollback of Biden-Era Fuel Economy Standards 



